WASHINGTON — Biotech breakthroughs are within U.S. reach, but policy shifts and proposed funding cuts could slow how those ...
White House science and technology adviser Michael Kratsios said on Wednesday at Axios' AI+DC Summit that the Trump administration can be bullish on AI innovation and still address the public's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results